Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF- ET?

Journal of Assisted Reproduction and Genetics

Volumn 17, Issue 3, 2000, Pages 140-146

  Al Mizyen, E ^a   Sabatini, L ^a   Lower, A M ^a   Wilson, C M Y ^a   Al Shawaf, T ^a   Grudzinskas, J G ^a,b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

'Flare' protocol; Controlled ovarian hyperstimulation; In vitro fertilization; Low responders; Pre in vitro fertilization treatment using oral contraceptive pill or gestogen

Indexed keywords

FOLLITROPIN; GESTAGEN; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; ORAL CONTRACEPTION; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CONTRACEPTIVES, ORAL; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENOTROPINS; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE CONGENERS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 0033928052     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009462004650     Document Type: Article

References (42)

1. Rosenwaks Z, Muasher SJ: Recruitment of fertilisable eggs. In In Vitro Fertilisation-Norfolk, HW Jones, Jr, GS Jones, GD Hodgen, Z Rosenwaks (eds). Baltimore, Williams & Wilkins, 1986, pp. 30-52
2. Jones HW, Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garica J, Sanddow B, Veeck L, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14-21
3. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gad SC, Waston RH: Comparison of "poor" responders with "good" responders using a standard buserelin/human menopausal gonadotrophin regime for in vitro fertilization. Hum Reprod 1991;6:918-921
4. Rysselberge MV, Puissant F, Barlow P, Lejeune B, Delvigne, Leroy F: Fertility prognosis in IVF treatment of patient with cancelled cycles. Hum Reprod 1989;4:663-666
5. Nargund G, Cheng W C, Parsons J: The impact of ovarian cystectomy on ovarian response to stimulation during in vitro fertilisation cycles. Hum Reprod 1995;11:81-83
6. Manzi DL, Thornton KL, Scott LB, Nulsen JC: The value of increasing the dose of human menopausal gonadotrophins in women who initially demonstrate a poor response. Fertil Steril 1994;65:961-965
7. Scott R Jr, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654
8. Toner JP, Philput CB, Jones GS: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791
9. Navot D, Rosenwaks Z, Margalioth E J: Prognostic assessment of female fecundity. Lancet 1987;2:645-647
10. Loumaye E: The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and embryo transfer. Hum Reprod 1990;5:357-376
11. Garcia JE, Padilla SL, Bayati J, Baramki TA: Follicular phase gonadotrophin-releasing hormone agonist and human gonadotrophins: A better alternative for ovulation induction in vitro fertilization. Fertil Steril 1990;53:302-305
12. Halvorson LM, DeCherney AH: Inhibin, activin and follistatin in reproductive medicine. Fertil Steril 1996;65:459-469
13. Syrop CH, Willhoite ABA, Van Voorhis BJ: Ovarian volume: A novel outcome predictor for assisted reproduction. Fertil Steril 1995;64:1167-1171
14. Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R, Winston R ML: Follicular density in ovarian biopsy of infertile women: A novel method to assess ovarian reserve. Hum Reprod 1997;12:1028-1031
15. Tomas C, Huttunen SN, Martikainen H: Pre-treatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in vitro fertilisation. Hum Reprod 1997;12: 220-223
16. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R: Exogenous follicle stimulating hormone ovarian reserve test (EFORT): A simple and reliable screening test for detecting "poor responders" in vitro fertilisation. Hum Reprod 1994; 9:1607-1611
17. Gonen Y, Jacobson W, Casper R F: Gonadotrophin suppression with oral contraceptives before in vitro fertilisation. Fertil Steril 1990;53:282-287
18. Check JH, Nowroozi K, Chase JS, Nazari A, Shape D, Vaze M: Ovulation induction and pregnancies in 100 consecutive women with hypergonadotrophic amenorrhoea. Fertil Steril 1990;53:811-816
19. Cedrin-Durnerin I, Bulwa S, Herve F, Martin-Pont B, Uzan M, Hugues JN: The hormonal flare-up following gonadotrophin releasing agonist administration is influenced by a progestogen pretreatment. Hum Reprod 1996;11:1859-1863
20. Keay S D, Liversedge N H, Mathur R S, Jenkins J M: Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-527
21. Speroff L, Glass RH, Kase NG: Assisted reproduction. In Clinical Gynecologic Endocrinology and Infertility, 5th ed. Baltimore, Williams and Wilkins, 1994, pp 931-946
22. Owen EJ, Shoham Z, Mason BA, Ostergaard H, Jacobs HS: Co-treatment with growth hormone, after pituitary suppression, for ovarian stimulation in vitro fertilisation: A randomised, double-blind, placebo-control trial. Fertil Steril 1991;56: 1104-1108
23. Russell JB: Precycle estrogen treatment and poor responders. Assisted Reprod Rev 1995;5:82-89
24. Hugues JN, Attalah M, Herve F, Martin-Pont B, Kottler ML, Santarelli J: Effects of short-term GnRH agonist-human menopausal gonadotropin stimulation in patients pre-treated with progestogen. Hum Reprod 1992;7:1079-1084
25. Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N: Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilisation. Fertil Steril 1997;67:900-903
26. Scott PT, Hofmann GE, Oehninger S: Intercycle variability of day 3 follicle-stimulating hormone concentration and its effect on stimulation quality in vitro fertilisation. Fertil Steril 1990; 54:297-302
27. Karande VC, Jones GS, Veeck LL, Muasher SJ: High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve in vitro fertilisation outcome in low responder patients. Fertil Steril 1990;53:486-489
28. Hofmann GE, Toner J P, Muasher SJ, Jones GS: High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low responder patients for in vitro fertilisation, in Vitro Fertil Embryo Transfer 1993;6:285-289
29. Rombauts L, Suikkari AM, MacLachlan V, Trounson AO, Healy DL: Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of ovarian cycle. Fertil Steril 1998;69:665-669
30. Sandow J, Donnez J: Clinical pharmaco-Kinetics of LHRH analogues. In LHRH Analogues in Gynaecology, I Brosen, HS Jacobs, B Runnebaum (eds). Carnforth, England, Parthenon Publishing, 1990, pp 17-31
31. Ben-Rafael Z., Feldberg D: The poor-responder patient in an in vitro fertilisation-embryo transfer program. J Assist Reprod Genet 1993; 10:118-120
32. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafeal Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343-346
33. Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman R: A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentration on day 3. Hum Reprod 1996; 11:1169-1172
34. Sims JA, Seltman HJ, Mausher SJ: Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotropin-releasing hormone agonist imparies follicular recruitment for in vitro fertilisation. Hum Reprod 1994;9:235-240
35. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation for in vitro fertilisation. Fertil Steril 1994; 61:880-885
36. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilisation patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93-97
37. Ibrahim ZHZ, Matson PL, Buck P, Lieberman BA: The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/ human menopausal gonadotropin in women with a poor ovarian response. Fertil Steril 1991;55:256-260
38. Bergh C, Hillensjo T, Wikland M, Nilsson L, Borg G, Hamberger L: Adjuvant growth hormone treatment during in vitro fertilisation: A randomised, placebo-controlled study. Fertil Steril 1994;62:113-120
39. Faber MB, Mayer J, Cox B, Jones D, Toner J P, Oehninger S, Muasher SJ: Cessation of gondotropin-releasimg hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998,69:826-830
40. Lass A, Skull J, McVeigh E: Measurements of ovarian volume by transvaginal sonography before human menopausal gonadotrophin superovulation for in vitro fertilisation can predict poor response. Hum Reprod 1997;12:294-297
41. Farhi J, Homburg R, Ferber A, Orvieto R, Rafael ZB: Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: A clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997;12:241-243
42. El-Nemr A, Al-Shawaf T, Sabatini L, Wilson C, Lower AM, Grudzinskas JG: Effect of smoking on ovarian reserve and controlled ovarian stimulation in in vitro fertilisation and embryo transfer. Hum Reprod 1998;13:2192-2198